IXICO PLC (IXI)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 9.750 |
|---|---|
| 52-week range | 6.260 – 13.000 |
| Return, 1 month / 3 months | +30.0% / +14.7% |
| Return, 1 year / 3 years | −18.8% / −31.6% |
| Trend | Uptrend |
| RSI (14) | 92 |
| Volatility (1 year) | 48.4% |
| Worst drawdown (1 year) | -45.9% |
| Average daily value traded | 0.59M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
IXICO is a healthcare data analytics company based in London that supports clinical trials for pharmaceutical and biotechnology customers. It specialises in the analysis and management of medical images and other clinical data, with a focus on disorders of the brain and central nervous system. Its services help trial sponsors collect, interpret and manage the information gathered during studies of new treatments.
The shares are listed on the London Exchange in UK under the code IXI, and the price on this page is in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
IXICO PLC (IXI) trades on the London Exchange in UK. It last closed at GBX 9.750 on 22 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,240 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.8% and over the last three months it rose 14.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 17.8% | ||
| From 52-week high | -20.4% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 14.7% | ||
| 6-month return | 36.8% | ||
| 12-month return, skipping the last month | -37.5% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.9% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.59M GBX | ||
| Zero-volume days | 6.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +25.8% |
|---|---|
| 1 month | +30.0% |
| 3 months | +14.7% |
| 6 months | +36.8% |
| 1 year | −18.8% |
| 3 years | −31.6% |
| 5 years | −86.4% |
Signals
| 50-day / 200-day average | 7.678 / 8.274 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.993 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.